Biomarker predictors of cardiac hospitalization in chronic heart failure: A recurrent event analysis

Journal of Cardiac Failure

Volumn 20, Issue 8, 2014, Pages 569-576

  Vorovich, Esther ^a   French, Benjamin ^a   Ky, Bonnie ^a   Goldberg, Lee ^a   Fang, James C ^b   Sweitzer, Nancy K ^c   Cappola, Thomas P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

BNP; recurrent hospitalization; sFlt 1; troponin

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; MYELOPEROXIDASE; PLACENTAL GROWTH FACTOR; TOLL LIKE RECEPTOR 2; TROPONIN I; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; TROPONIN;

ADULT; ARTICLE; FEMALE; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY (TOPIC); NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PROGNOSIS; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RECURRENCE; TROPONIN; UNITED STATES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84905487321     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.05.013     Document Type: Article

References (34)

1. M. Gheorghiade, M. Vaduganathan, G.C. Fonarow, and R.O. Bonow Rehospitalization for heart failure: problems and perspectives J Am Coll Cardiol 61 2013 391 403
2. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, and W.B. Borden et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
3. E. Braunwald Heart failure JACC: Heart Fail 1 2013 1 20
4. R.D. Kociol, S.E. McNulty, A.F. Hernandez, K.L. Lee, M.M. Redfield, and R.P. Tracy et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure Circ Heart Fail 6 2013 240 245
5. S.D. Anker, and J.J. McMurray Time to move on from "time-to- first": should all events be included in the analysis of clinical trials? Eur Heart J 33 2012 2764 2765
6. A.S. Desai, and L.W. Stevenson Rehospitalization for heart failure: predict or prevent? Circulation 126 2012 501 506
7. E.H. Bradley, L. Curry, L.I. Horwitz, H. Sipsma, Y. Wang, and M.N. Walsh et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure Circ Cardiovasc Qual Outcomes 6 2013 444 450
8. B. Ky, B. French, W.C. Levy, N.K. Sweitzer, J.C. Fang, and A.H. Wu et al. Multiple biomarkers for risk prediction in chronic heart failure Circ Heart Fail 5 2012 183 190
9. E.A. Peña, R. Strawderman, and M. Hollander Nonparametric estimation with recurrent event data J Am Stat Assoc 96 2001 1299 1315
10. V. Rondeau, S. Mathoulin-Pelissier, H. Jacqmin-Gadda, V. Brouste, and P. Soubeyran Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events Biostatistics 8 2007 708 721
11. V. Rondeau, Y. Mazroui, and J.R. Gonzalez Frailtypack: an R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametrical estimation J Stat Softw 47 2012 1 28
12. B. Lau, S.R. Cole, and S.J. Gange Competing risk regression models for epidemiologic data Am J Epidemiol 170 2009 244 256
13. P.A. Heidenreich, A. Sahay, J.R. Kapoor, M.X. Pham, and B. Massie Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006 J Am Coll Cardiol 56 2010 362 368
14. I.S. Anand, L.D. Fisher, Y.T. Chiang, R. Latini, S. Masson, and A.P. Maggioni et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) Circulation 107 2003 1278 1283
15. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, M. Lopatin ADHERE Scientific Advisory Committee and Investigators Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
16. M.P. Hudson, C.M. O'Connor, W.A. Gattis, G. Tasissa, V. Hasselblad, and C.M. Holleman et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis Am Heart J 147 2004 546 552
17. R. Latini, S. Masson, I.S. Anand, E. Missov, M. Carlson, and T. Vago et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 116 2007 1242 1249
18. W.L. Miller, K.A. Hartman, M.F. Burritt, D.E. Grill, and A.S. Jaffe Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure J Am Coll Cardiol 54 2009 1715 1721
19. J.T. Parissis, I. Ikonomidis, P. Rafouli-Stergiou, A. Mebazaa, J. Delgado, and D. Farmakis et al. Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction Am J Cardiol 107 2011 79 84
20. E.R. Perna, S.M. Macin, J.P. Canella, N. Augier, J.L. Stival, and J.R. Cialzeta et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification Circulation 110 2004 2376 2382
21. D.J. van Veldhuisen, G.C. Linssen, T. Jaarsma, W.H. van Gilst, A.W. Hoes, and J.G. Tijssen et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 2013 1498 1506
22. T.B. Horwich, J. Patel, W.R. MacLellan, and G.C. Fonarow Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure Circulation 108 2003 833 838
23. W.L. Miller, K.A. Hartman, M.F. Burritt, D.E. Grill, R.J. Rodeheffer, and J.C. Burnett Jr. et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 2007 249 257
24. D.L. Dries, D.V. Exner, M.J. Domanski, B. Greenberg, and L.W. Stevenson The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689
25. H.L. Hillege, D. Nitsch, M.A. Pfeffer, K. Swedberg, J.J. McMurray, and S. Yusuf et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 2006 671 678
26. B. Ky, B. French, K. Ruparel, N.K. Sweitzer, J.C. Fang, and W.C. Levy et al. The vascular marker soluble Fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure J Am Coll Cardiol 58 2011 386 394
27. I.S. Patten, S. Rana, S. Shahul, G.C. Rowe, C. Jang, and L. Liu et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy Nature 485 2012 333 338
28. S. Sanada, D. Hakuno, L.J. Higgins, E.R. Schreiter, A.N. McKenzie, and R.T. Lee IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system J Clin Invest 117 2007 1538 1549
29. W.H. Tang, K. Shrestha, R.W. Troughton, A.G. Borowski, and A.L. Klein Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure Congest Heart Fail 17 2011 105 109
30. W.H. Tang, W. Tong, R.W. Troughton, M.G. Martin, K. Shrestha, and A. Borowski et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure J Am Coll Cardiol 49 2007 2364 2370
31. A.H. Wu, J.K. Ghali, G.W. Neuberg, C.M. O'Connor, P.E. Carson, and W.C. Levy Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure Am Heart J 160 2010 928 933
32. W.H. Yin, J.W. Chen, H.L. Jen, M.C. Chiang, W.P. Huang, and A.N. Feng et al. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure Am Heart J 147 2004 931 938
33. S.D. Anker, W. Doehner, M. Rauchhaus, R. Sharma, D. Francis, and C. Knosalla et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging Circulation 107 2003 1991 1997
34. B. Ky, B. French, K. McCloskey, J.E. Rame, E. McIntosh, and P. Shahi et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure Circ Heart Fail 4 2011 180 187